epolamine

We are epolamine CAS:2955-88-6 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:  epolamine
CAS.NO:2955-88-6
Molecular Formula:C6H13NO
Molecular Weight:115.17400

Synonyms:
2-Pyrrolidinoethanol
Epolamine
2-(Pyrrolidin-1-yl)ethanol
N-(2-Hydroxyethyl)pyrrolidine
1-(2-Hydroxyethyl)pyrrolidine
N-hydroxyethyl pyrrolidine
1-Pyrrolidineethanol
1-pyrrolinineethanol
Pyrrolidinoethanol
2-pyrrolidin-1-ylethanol

Physical and Chemical Properties:
Density: 0.985 g / mL at 25 ° C (lit.)
Boiling point: 79-81 ° C13 mm Hg (lit.)
Flash point: 133 ° F
Refractive index: n20 / D 1.473

Specification:
Appearance:Light Yellow Liquid
Purity:≥99.0%
Pyrrolidine content:<0.1%
Water:≤0.2%

Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.
Application:Epolamine is a very useful synthetic intermediate. It is a reagent used to synthesize Diclofenac Epolamine which is a diclofenac salt with greater water solubility and better cutaneous absorption properties than other commonly used forms of the drug.

epolamine


Related News: “We will continue to closely monitor the situation and we look forward to reopening our stores as soon as possible.”54381-08-7 Onconova Therapeutics, Inc. and Inceptua Medicines Access (a business unit of the Inceptua Group) recently announced they have entered into a collaboration to make available intravenous rigosertib via a Pre-approval Access Program in selected countries around the world.2-cloro-5-metil-3-nitropiridina CAS:23056-40-8 Onconova Therapeutics, Inc. and Inceptua Medicines Access (a business unit of the Inceptua Group) recently announced they have entered into a collaboration to make available intravenous rigosertib via a Pre-approval Access Program in selected countries around the world.2,4-Difluorobenzyl Alcohol CAS:56456-47-4 Onconova Therapeutics, Inc. and Inceptua Medicines Access (a business unit of the Inceptua Group) recently announced they have entered into a collaboration to make available intravenous rigosertib via a Pre-approval Access Program in selected countries around the world.Onconova Therapeutics, Inc. and Inceptua Medicines Access (a business unit of the Inceptua Group) recently announced they have entered into a collaboration to make available intravenous rigosertib via a Pre-approval Access Program in selected countries around the world.

Related Products
Product Name
5-(chloromethyl)-1,2-dihydro-1,2,4-triazol-3-one View Details
2-Amino-4-chlorobenzoic acid View Details
1-Bromo-8-chloronaphthalene View Details
4-Ethylbenzoyl chloride manufacturer 4-Fluorobenzyl Bromide manufacturer 2,6-Difluoronitrobenzene manufacturer 1-iodohexan-6-ol manufacturer 3-iodo-4-methyl-N-[3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl]benzamide manufacturer